FilingReader Intelligence
Challenger postpones investor day for regulatory talks
August 25, 2025 at 10:04 AM UTC•By FilingReader AI
Challenger Limited has postponed its 2025 Investor Day to consult with APRA on capital settings for annuity products, with other key financial dates remaining unchanged.
The company has also ceased to be a substantial holder in Telix Pharmaceuticals and The A2 Milk Company as of August 21, 2025, following various market transactions.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
Primary Source Document
ASX:CGF•Australian Securities Exchange
News Alerts
Get instant email alerts when Challenger Limited publishes news
Free account required • Unsubscribe anytime